UNIGE document Scientific Article
previous document  unige:1883  next document
add to browser collection
Title

Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda

Authors
Mueller, Y.
Nguimfack, A.
Cavailler, P.
Couffignal, S.
Rwakimari, J B.
Published in Annals of Tropical Medicine and Parasitology. 2008, vol. 102, no. 1, p. 11-9
Abstract Between September 2003 and April 2004, the supply of antimonial drugs to Amudat Hospital, in north-eastern Uganda, was interrupted and all cases of visceral leishmaniasis presenting at the hospital could only be treated with amphotericin B deoxycholate (AmB). This allowed the safety and effectiveness of the AmB to be evaluated, in comparison with an historical cohort of patients treated, at the same hospital, with meglumine antimoniate (Sb(V)). Demographic and clinical data were collected before and after treatment. Adverse effects were recorded passively in all the subjects, and actively, using a standardized questionnaire, in a sub-group of the patients given AmB. The in hospital case-fatality 'rates' were 4.8% [95% confidence interval (CI) = 2.4%-8.8%] among the 210 patients treated with AmB and 3.7% (CI = 1.4%-7.9%) among the 161 patients treated with Sb(V) (P>0.20). Adverse effects requiring treatment interruption were rare in both cohorts. Treatment failures (i.e. non-responses or relapses) were observed in 2.9% (CI = 1.2%-6.4%) of the patients treated with AmB and 1.2% (CI = 0.1%-4.4%) of the patients treated with Sb(V) (P>0.20). For the treatment of visceral leishmaniasis in Uganda, AmB therefore had a similar effectiveness and safety profile to that of meglumine antimoniate.
Keywords AdolescentAdultAgedAged, 80 and overAmphotericin B/adverse effectsAnimalsAntiprotozoal Agents/adverse effectsChildChild, PreschoolCohort StudiesFemaleHumansInfantKenyaLeishmania donovani/parasitologyLeishmaniasis, Visceral/drug therapy/epidemiologyMaleMeglumine/therapeutic useMiddle AgedOrganometallic Compounds/therapeutic useStatistics as TopicTreatment OutcomeUganda
Identifiers
PMID: 18186974
Full text
Structures
Research groups Groupe Louis Loutan (médecine des Voyages et des Migrations, Médecine Tropicale, Santé Internationale) (122)
Groupe Jean-Michel Gaspoz (23)
Citation
(ISO format)
MUELLER, Y. et al. Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda. In: Annals of Tropical Medicine and Parasitology, 2008, vol. 102, n° 1, p. 11-9. https://archive-ouverte.unige.ch/unige:1883

213 hits

0 download

Update

Deposited on : 2009-06-04

Export document
Format :
Citation style :